MOST COMMENTED
Immunocore and Medison Pharma collaborate to market Tebentafusp in Canada
Ontario, Canada (CU)_ Immunocore, which is a late-stage biotechnology firm creating a unique class of bispecific T cell receptor (TCR) bispecific immunotherapies for the...
